Ambeed.cn

首页 / 抑制剂/激动剂 / 神经信号通路 / FAAH / URB-597

URB-597 {[allProObj[0].p_purity_real_show]}

货号:A724051 同义名: KDS-4103

URB-597 is fatty acid amide hydrolase (FAAH, IC50 = 4.6 nM) inhibitor without effect on other cannabinoid-related targets.

URB-597 化学结构 CAS号:546141-08-6
URB-597 化学结构
CAS号:546141-08-6
URB-597 3D分子结构
CAS号:546141-08-6
URB-597 化学结构 CAS号:546141-08-6
URB-597 3D分子结构 CAS号:546141-08-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

URB-597 纯度/质量文件 产品仅供科研

货号:A724051 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >
产品名称 FAAH 其他靶点 纯度
URB-597 ++++

FAAH, IC50: 4.6 nM

99%
JNJ-1661010 +++

FAAH (human), IC50: 12 nM

FAAH (rat), IC50: 10 nM

99%
Biochanin A +

FAAH (human), IC50: 1.4 μM

FAAH (mouse), IC50: 1.8 μM

EGFR 98+%
PF-3845 ++

FAAH, Ki: 230 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

URB-597 生物活性

靶点
  • FAAH

    FAAH, IC50:4.6 nM

描述 Fatty acid amide hydrolase (FAAH), an integral membrane bound enzyme, are intracellular enzymes responsible for the hydrolysis of endogenous fatty acid ethanolamides (FAEs). URB-597 (KDS-4103) is FAAH inhibitor with IC50 of 4.6 nM without effect on other cannabinoid-related targets[3]. Treatment with 10 μM URB-597 in microglial cells reduced the release of PGE2 to approximately 50% of control, and inhibited LPS stimulated TNF and NO release and iNOS expression[4]. In vivo, URB-597 (0.3 mg/kg/day, intraperitoneal (i.p.) injection) treatment in chronic cerebral hypoperfusion model inhibited impaired autophagy degradation and the disruption of beclin-1/Bcl-2 complex and subsequently cut off BNIP3-cyt C- and parkin-required mitophagy, finally preventing the abnormal excessive autophagy and mitophagy[5].
作用机制 Carbamoyl group in URB-597 may form two distinct hydrogen bonds with FAAH: one as an acceptor, with the hydroxyl group of Thr488, and the other as a donor, with the main chain carbonyl group of Leu192.

URB-597 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00916201 Schizophrenia Phase 1 Not yet recruiting December 2020 Germany ... 展开 >> Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health Not yet recruiting Mannheim, BW, Germany, 68159 Contact: F. Markus Leweke, MD    +49 621 1703 ext 2321    leweke@cimh.de    Contact: Cathrin Rohleder, PhD    +49 621 1703 ext 2333    rohleder@cimh.de    Sub-Investigator: J. Malte Bumb, MD          Sub-Investigator: Cathrin Rohleder, PhD          Sub-Investigator: Till van der List, MD          Sub-Investigator: Juliane K. Mueller, MD          Sub-Investigator: Frank Enning, MD 收起 <<

URB-597 参考文献

[1]Tham CS, Whitaker J, et al. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators. FEBS Lett. 2007 Jun 26;581(16):2899-904.

[2]Mor M, Rivara S, et al. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem. 2004 Oct 7;47(21):4998-5008.

[3]Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem. 2004 Oct 7;47(21):4998-5008. doi: 10.1021/jm031140x. PMID: 15456244.

[4]Tham CS, Whitaker J, Luo L, Webb M. Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators. FEBS Lett. 2007 Jun 26;581(16):2899-904. doi: 10.1016/j.febslet.2007.05.037. Epub 2007 May 25. PMID: 17543306.

[5]Su SH, Wu YF, Wang DP, Hai J. Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion. Cell Death Dis. 2018 Jun 28;9(7):733. doi: 10.1038/s41419-018-0755-y. PMID: 29955058; PMCID: PMC6023888.

URB-597 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.55mL

5.91mL

2.96mL

URB-597 技术信息

CAS号546141-08-6
分子式C20H22N2O3
分子量 338.4
别名 KDS-4103
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,Room Temperature

溶解度

DMSO: 105 mg/mL(310.28 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

5%DMSO+40%PEG300+5%Tween80+water 1 mg/mL

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。